Put Options

16 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 15, 2024

BUY
$61.89 - $69.28 $5.63 Million - $6.3 Million
90,900 New
90,900 $6.12 Million
Q1 2023

May 04, 2023

BUY
$63.15 - $71.6 $3.79 Million - $4.3 Million
60,000 Added 73.62%
141,500 $9.82 Million
Q4 2022

Feb 13, 2023

BUY
$54.21 - $70.44 $4.42 Million - $5.74 Million
81,500 New
81,500 $5.53 Million
Q4 2021

Feb 14, 2022

SELL
$54.02 - $63.83 $10,804 - $12,766
-200 Reduced 11.76%
1,500 $87,000
Q2 2020

Aug 12, 2020

SELL
$43.1 - $55.31 $2.6 Million - $3.34 Million
-60,400 Reduced 97.26%
1,700 $90,000
Q1 2020

May 13, 2020

SELL
$37.79 - $51.33 $3.33 Million - $4.52 Million
-88,100 Reduced 58.66%
62,100 $2.77 Million
Q4 2019

Feb 10, 2020

BUY
$42.46 - $50.46 $309,958 - $368,358
7,300 Added 5.11%
150,200 $7.49 Million
Q3 2019

Nov 14, 2019

SELL
$40.12 - $45.47 $20.4 Million - $23.1 Million
-508,400 Reduced 78.06%
142,900 $6.37 Million
Q2 2019

Aug 14, 2019

BUY
$37.28 - $41.68 $22.3 Million - $25 Million
599,300 Added 1152.5%
651,300 $26.9 Million
Q1 2019

May 15, 2019

BUY
$35.49 - $43.02 $159,705 - $193,590
4,500 Added 9.47%
52,000 $2.1 Million
Q4 2018

Feb 14, 2019

BUY
$36.86 - $41.49 $239,590 - $269,685
6,500 Added 15.85%
47,500 $1.8 Million
Q3 2018

Nov 14, 2018

SELL
$34.76 - $39.72 $4.28 Million - $4.89 Million
-123,000 Reduced 75.0%
41,000 $1.62 Million
Q2 2018

Aug 14, 2018

BUY
$34.55 - $37.05 $431,874 - $463,124
12,500 Added 8.25%
164,000 $5.76 Million
Q1 2018

May 15, 2018

SELL
$32.97 - $36.63 $7.99 Million - $8.88 Million
-242,300 Reduced 61.53%
151,500 $5.3 Million
Q4 2017

Feb 14, 2018

BUY
$32.09 - $34.78 $234,257 - $253,894
7,300 Added 1.89%
393,800 $13.7 Million
Q3 2017

Nov 14, 2017

BUY
$28.96 - $34.0 $11.2 Million - $13.1 Million
386,500
386,500 $13.1 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $233B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.